Key facts
- This page summarizes Jr. Charles J. Link's Form 4 filing for QSAM Biosciences, Inc..
- 1 reported transaction and 2 derivative rows are listed below.
- Accepted by SEC: 23 Jun 2023, 16:30.
Jr. Charles J. Link - 23 Jun 2023 Form 4 Insider Report for QSAM Biosciences, Inc.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 23 Jun 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 23 Jun 2023, 16:30:43 UTC
- Prior SEC filing
- 08 Mar 2022
- Next SEC filing
- 02 May 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Charles Link Jr.
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jr. Charles J. Link filed Form 4 for QSAM Biosciences, Inc. on 23 Jun 2023.
Change
- Previous filing in this sequence was filed on 08 Mar 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
QSAM
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +10,455
- Change %
- +15%
- Price
- $0.000000
- Shares after
- 82,464
- Date
- 23 Jun 2023
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
QSAM
holding
Derivative
Options to buy common stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,375
- Date
- 23 Jun 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,375
- Exercise price
- $14.40
- Footnotes
- F2
QSAM
holding
Derivative
Options to buy common stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 25,000
- Date
- 23 Jun 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 25,000
- Exercise price
- $8.00
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
This award of shares is being made pursuant to the Issuer's restricted stock award agreement and is subject to a vesting schedule, such that a portion or all of this award of restricted stock may be forfeited in the future if certain milestones are not met.
Footnote F2
The option vests semi-annually in two equal installments beginning on 2/24/2022.